Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-05-09
2006-05-09
Wilson, James O. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S364100, C548S300100, C548S358100
Reexamination Certificate
active
07041687
ABSTRACT:
The present invention provides compounds of formula I:or a pharmaceutically acceptable derivative thereof, wherein R1, R2, V1, V2, and V3are as described in the specification. These compounds are inhibitors of protein kinase, particularly inhibitors of AKT, PKA, PDK1, p70S6K, or ROCK kinase, mammalian protein kinases involved in proliferative and neurodegenerative disorders. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of utilizing those compositions in the treatment of various disorders.
REFERENCES:
patent: 2002/0103229 (2002-08-01), Bhagwat et al.
patent: WO 00/71508 (2000-11-01), None
patent: WO 00/76971 (2000-12-01), None
patent: WO 01/56988 (2001-08-01), None
patent: WO 01/85719 (2001-11-01), None
patent: WO 02/10137 (2002-02-01), None
patent: WO 02/083648 (2002-10-01), None
patent: WO 02/100833 (2002-12-01), None
Nicolaides, E.D., et al., “Potential antiviral agents,” J. Med. Chem., 11(1):74-79 (1968).
Binch Hayley
Brenchley Guy
Golec Julian M. C.
Knegtel Ronald
Mortimore Michael
Dixon Lisa A.
Johnsen Jason H.
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Wilson James O.
LandOfFree
Indazole compounds useful as protein kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indazole compounds useful as protein kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indazole compounds useful as protein kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3614127